Louisiana State Employees Retirement System Takes Position in Inspire Medical Systems, Inc. $INSP

Louisiana State Employees Retirement System acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 11,500 shares of the company’s stock, valued at approximately $593,000.

A number of other large investors have also added to or reduced their stakes in the business. Wellington Management Group LLP bought a new stake in Inspire Medical Systems during the 4th quarter worth approximately $203,929,000. Wasatch Advisors LP raised its stake in shares of Inspire Medical Systems by 7.2% during the second quarter. Wasatch Advisors LP now owns 1,634,395 shares of the company’s stock valued at $212,095,000 after acquiring an additional 110,288 shares during the last quarter. Morgan Stanley raised its stake in shares of Inspire Medical Systems by 179.5% during the fourth quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock valued at $116,188,000 after acquiring an additional 809,121 shares during the last quarter. Deerfield Management Company L.P. lifted its holdings in shares of Inspire Medical Systems by 648.4% during the third quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock worth $77,739,000 after purchasing an additional 907,694 shares during the period. Finally, State Street Corp lifted its holdings in shares of Inspire Medical Systems by 2.3% during the second quarter. State Street Corp now owns 1,030,902 shares of the company’s stock worth $133,780,000 after purchasing an additional 22,843 shares during the period. Institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on INSP shares. Oppenheimer restated a “market perform” rating on shares of Inspire Medical Systems in a report on Monday, June 15th. Royal Bank Of Canada downgraded Inspire Medical Systems from a “sector perform” rating to a “buy” rating in a report on Monday, June 15th. Piper Sandler lowered Inspire Medical Systems from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $85.00 to $55.00 in a research report on Tuesday, May 5th. Truist Financial decreased their price target on Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a research note on Tuesday, May 5th. Finally, Mizuho lowered their price objective on Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating for the company in a research report on Tuesday, May 5th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, thirteen have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Inspire Medical Systems currently has an average rating of “Hold” and a consensus price target of $81.05.

Inspire Medical Systems Stock Up 1.4%

INSP stock opened at $50.14 on Wednesday. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 11.17, a PEG ratio of 5.01 and a beta of 0.71. The company’s fifty day simple moving average is $44.31 and its 200 day simple moving average is $61.08. Inspire Medical Systems, Inc. has a 12-month low of $38.91 and a 12-month high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. The firm had revenue of $204.58 million during the quarter, compared to the consensus estimate of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business’s revenue was up 1.6% compared to the same quarter last year. During the same period last year, the business posted $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Research analysts expect that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.